All EDQM press releases
EDQM experts recommend further research on the safety of inks and tattoos
The European Directorate for the Quality of Medicines & HealthCare (EDQM) today issued a compendium of the scientific information currently available on the potential toxicity of intradermal inks.
Pharmacopoeial discussion group achievements
The meeting of the Pharmacopoeial Discussion Group (PDG) [European Pharmacopoeia (Ph.Eur.), Japanese Pharmacopoeia (JP), and the United States Pharmacopoeia (USP)] was hosted by USP in Rockville, Maryland, U.S.A., September 12 – 13 2017.
EDQM highlights importance of guiding Blood Establishments (BEs) in implementing quality standards
The EDQM has cast a light on the importance of supporting Blood Establishments (BEs) in implementing Quality Management (QM) elements such as risk management, change control and validation/qualification, as well as of delineating their practical implementation.
Microbiological control symposium: consensus on readiness of new methods emerges
20 October 2017, Strasbourg, France Microbiological control symposium: consensus on readiness of new methods emerges A symposium on microbiology in the pharmaceutical sector was the opportunity for the EDQM to gather feedback from users of the European Pharmacopoeia on alternative testing...
EDQM discusses the place of its Certification procedure (CEPs) in the global regulatory environment
The EDQM held a 2-day conference in Prague to exchange with the worldwide pharmaceutical sector and to keep authorities and manufacturers alike informed of recent developments and of the future of its Certification of suitability to the monographs of the European Pharmacopoeia in the global...
